University of Colorado Hospital
Aurora, Colorado, 80045, United States
NCT Number: NCT01516801
1. Does a one-page American College of Physicians educational flyer about the pros and cons of prostate cancer screening sent to men within two weeks of their scheduled annual health examinations in a general medicine clinic result in a different rate of prostate cancer screening than among men who were not sent the flyer? 2. Do patients find the flyer useful and understandable?
Context: The use of prostate specific antigen (PSA) screening for prostate cancer is controversial because of a lack of evidence that such screening saves lives when applied within a population and because such testing can lead to invasive downstream biopsies and aggressive treatment that is associated with a high risk of permanent side effects (e.g. impotence, incontinence). Almost all professional societies (American Cancer Society, American Urologic Association, American College of Physicians, United States Preventive Services Task Force) advocate that patients receive education and complete an informed decision-making discussion with their medical providers about the pros and cons of the PSA test, as well as their personal preferences, before proceeding with this test. Unfortunately, despite these recommendations, there is seldom sufficient time during clinic visits to achieve this goal.
Looking for future studies?
Notify Me50 year–74 year
Male
Interventional
Not applicable
Aurora, Colorado, 80045, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A mailed low-literacy informational patient flyer about the PSA test
Time frame: At the time of the annual exam (within two weeks of their annual physical)
Rate of PSA testing will be determined by reviewing the chart of enrolled patients within two weeks of their annual physical
Time frame: At the time of the annual exam (within two weeks of their annual physical)
Rate of documented PSA discussions will be determined through chart review within two weeks of the annual physical.
Time frame: Within two weeks of the annual exam
The acceptability of the flyer will be assessed through a follow-up phone interview of patients who had received the flyer.
Time frame: Within two weeks
Perceived participation will be assessed in a follow-up phone interview within two weeks of the annual physical using validated measures of particiption in decision making.
Time frame: Within two weeks
Prostate cancer screening knowledge will be assessed using 5 knowledge questions surrounding PSA testing during a follow-up interview 2 weeks after the annual physical
University of Colorado, Denver
Other
A Pragmatic Randomized Trial of the Effect of a Mailed Patient Flyer About PSA Testing Prior to an Annual Exam
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06838325
Prostate Cancer Screening
Houston, Texas, United States
View Trial DetailsNCT07206693
Genital Diseases, Genital Diseases, Male
Stockholm, Sweden
View Trial DetailsNCT04601272
Breast Cancer Screening, Colon Cancer Screening
Boston, Massachusetts, United States
View Trial DetailsNCT04063566
Genital Diseases, Genital Diseases, Male
London, United Kingdom
View Trial Details